The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression

https://doi.org/10.1016/j.cell.2018.03.029 19th April 2018

Article highlights & insights

The majority of newly diagnosed prostate cancers are slow growing, with a long natural life history. Yet a subset can metastasize with lethal consequences. We reconstructed the phylogenies of 293 localised prostate tumors linked to clinical outcome data. Multiple subclones were detected in 59% of patients, and specific subclonal architectures associate with adverse clinicopathological features.

Early tumour development is characterised by point mutations and deletions followed by later subclonal amplifications and changes in trinucleotide mutational signatures. Specific genes are selectively mutated prior to or following subclonal diversification, including MTOR, NKX3-1, and RB1. Patients with low-risk monoclonal tumours rarely relapse after primary therapy (7%), while those with high-risk polyclonal tumours frequently do (61%).

The presence of multiple subclones in an index biopsy may be necessary, but not sufficient, for relapse of localised prostate cancer, suggesting that evolution-aware biomarkers should be studied in prospective studies of low-risk tumours suitable for active surveillance.

Institute Authors

Group leader

Research topics & keywords

Meet the Research Team

Rob Bristow

Senior Group Leader

iD
non-gendered icon
Lucy Barton

PhD Student

Giselle Edge

Postdoctoral Scientist

Neha Goel

Postdoctoral Scientist

non-gendered icon
Steve Lyons

Senior Scientific Officer

non-gendered icon
Diego Sanchez

Clinical Fellow

Shaun Scaramuzza Postdoctoral Fellow
Shaun Scaramuzza

Postdoctoral Scientist

All publications

Filter by group
Filter by group leader
Filter by research topic
Filter by year
Search publications

https://doi.org/10.1038/s41420-025-02582-x

Mutant p53 induces SH3BGRL expression to promote cell engulfment

1 July 2025

Institute Authors (5)

Garry Ashton, John Weightman, Wolfgang Breitwieser, Sudhakar Sahoo, Antonia Banyard

Labs & Facilities

Computational Biology Support, Flow Cytometry, Molecular Biology

array(3) { [0]=> int(3839) [1]=> int(2104) [2]=> int(3827) }

https://doi.org/10.1016/j.celrep.2025.115603

Functional characterisation of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancer

27 May 2025

Institute Authors (2)

Caroline Dive, Kathryn Simpson

Research Group

Small Cell Lung Cancer Biology

array(1) { [0]=> int(1156) }

https://doi.org/10.1016/j.ccell.2025.04.001

Stromal lipid species dictate melanoma metastasis and tropism

24 April 2025

Institute Authors (5)

Amaya Viros, Duncan Smith, Garry Ashton, Alex Baker, Tim Somervaille

Labs & Facilities

Biological Mass Spectrometry, Histology, Visualisation, Irradiation and Analysis

array(3) { [0]=> int(3758) [1]=> int(3150) [2]=> int(3154) }

Research Group

Skin Cancer & Ageing

array(1) { [0]=> int(2344) }

https://doi.org/10.1038/s41467-025-58343-y

A human model to deconvolve genotype-phenotype causations in lung squamous cell carcinoma

4 April 2025

Institute Authors (4)

Carlos Lopez-Garcia (Former Institute Fellow), Robert Sellers, Sudhakar Sahoo, Caroline Dive

Labs & Facilities

Computational Biology Support

array(1) { [0]=> int(3839) }

Research Group

Former Group: Translational Lung Cancer Biology

array(1) { [0]=> int(2321) }

https://doi.org/10.1186/s12943-024-02157-x

The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer

12 November 2024

Institute Authors (1)

Amaya Viros

Labs & Facilities

Genome Editing and Mouse Models

array(1) { [0]=> int(2947) }

Research Group

Skin Cancer & Ageing

array(1) { [0]=> int(2344) }

https://doi.org/10.1186/s13045-024-01610-0

The small inhibitor WM-1119 effectively targets KAT6A-rearranged AML, but not KMT2A-rearranged AML, despite shared KAT6 genetic dependency

8 October 2024

Institute Authors (6)

Georges Lacaud, Mathew Sheridan, Michael Lie-a-ling, Liam Clayfield, Jessica Whittle, Jingru Xu

Research Group

Stem Cell Biology

int(2449)